Keywords: USA, PhRMA, Drug prices, Rebates, Medicare

USA’s PhRMA refutes NYT story on drug prices

Article | 18 November 2009

• Print This

Pharmaceutical Research and Manufacturers of America (PhRMA), the USA drug industry lobby group, has strongly contested the allegations in a front page New York Times story that suggested that drugmakers raised their prices by 9% this year in order to cushion themselves from the steep cuts in drug spending that are included in the country’s health reform plans. That will add more than $10 billion to the nation’s drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992, the NYT article claimed.

T Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.